Skip to main content
. Author manuscript; available in PMC: 2016 Apr 25.
Published in final edited form as: J Immunol. 2008 Nov 15;181(10):6872–6881. doi: 10.4049/jimmunol.181.10.6872

Figure 9.

Figure 9

AVDCs resist viral infection. A) Barcoding for flow cytometry analysis. Cells were stained with different combinations of 0, 0.3, 1, 4 or 15 μg/ml Pacific Blue–NHS, 0, 1.25, 5 or 20 μg/ml Alexa 350–NHS and 0, 4 or 20 μg/ml Alexa 750–NHS to enable 60 different conditions in one FACS run. B) Time course results for NDV-RFP expression following infection in naïve DC and AVDC. C) Time course for expression of MHC-I, MHC-II and CD86 surface markers in the same cells studied in A and B. The results shown are representative of two independent experiments using cells from different donors.

HHS Vulnerability Disclosure